Company Search:
Advanced Search
Sponsored Links
BioSino Bio-technology and Science Inc Company Snapshot
BioSino Bio-technology and Science Inc operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares BioSino Bio-technology and Science Inc with three other pharmaceutical manufacturers in Asia: Mizuho Medy Co Ltd of Japan (2015 sales of 4.08 billion Japanese Yen [US$39.31 million] ), Kainos Laboratories, Inc. of Japan (5.48 billion Japanese Yen [US$52.74 million] ), and Bionime Corporation which is based in Taiwan (1.61 billion Taiwanese Dollars [US$50.69 million] of which 100% was Manufacturing Medical Equipment & Medica).

Sales Analysis. BioSino Bio-technology and Science Inc reported sales of 290.38 million Chinese Renmimbi (US$42.91 million) for the year ending December of 2015. This represents an increase of 9.4% versus 2014, when the company's sales were 265.33 million Chinese Renmimbi. This was the fourth straight year of sales growth at BioSino Bio-technology and Science Inc.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BioSino Bio-technology and Science Inc
  Stock Performance Chart for BioSino Bio-technology and Science Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/20/2016): 2.74
(Figures in Chinese Renmimbi)
1 Week 0.3%   13 Weeks 0.2%  
4 Weeks 4.3%   52 Weeks 11.4%  
BioSino Bio-technology and Science Inc Key Data:
  Ticker: 8247 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 290,380,000
(Year Ending Jan 2016).
Employees: 650
  Currency: Chinese Renmimbi Market Cap: 359,600,051
  Fiscal Yr Ends: December Shares Outstanding: 131,303,671
  Share Type: H Gu Closely Held Shares: 104,853,671
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.